. Author manuscript; available in PMC: 2007 Apr 24.

Published in final edited form as: Endocrinology. 2003 Sep 18;145(1):401–406. doi: 10.1210/en.2003-0746

TABLE 2.

Relative expression of phenotype-specific gene markers in the whole tibia normalized to 18 S rRNA

Treatment	Runx2/Cbfa1	Dlx5	Osteocalcin	α1 (I) collagen	aP2
Control	9.3 ± 1.8	9.0 ± 1.9	7.6 ± 3.7	10.3 ± 0.7	3.2 ± 0.2
Rosiglitazone	6.4 ± 0.1^a	6.4 ± 0.7^a	7.4 ± 0.8	5.5 ± 1.1^a	13.5 ± 1.9^a
Ratio (rosiglitazone/vehicle)	0.6	0.7	1.0	0.6	3.4

Data are given as mean ± SD; n = 4 animals per group.

P < 0.05 vs. control.